Ä¢¹½´«Ã½

With over 25 years of experience in venture capital, Mr. Wiegman has directly participated in 50 early-stage venture investments in software, healthcare IT, medical devices and healthcare services. A hands-on board member, he is passionate about investment and value-creation processes combined with a unique blend of strategic and operational expertise.

Adi Shaked joined FMCV in June 2020 as Venture Innovation Manager, Israel. Adi is responsible for evaluating investment opportunities in Israel.
Prior to joining FMCV, Adi spent 10 years as Deal Flow Manager at SCP Vitalife and was Marketing Manager at Medtronic Vascular in the U.S.Ìý
Adi brings a strong business development and marketing background in Medical Devices and has a professional passion in making a meaningful impact on peopleÄ¢¹½´«Ã½™s lives.

Christof Koester joined Ä¢¹½´«Ã½ in 2009 and since then held various roles in the Global Legal Functions. He currently holds the position of Senior Vice President, Head of Corporate Governance and Legal Cross-Business. He was appointed Managing Director of Ä¢¹½´«Ã½ Ventures GmbH in May 2024. Christof holds law degrees from University of Passau, Germany, and the University of Pennsylvania Carey Law School (Master of Laws, LL.M.). Prior to joining FME he worked as an attorney in private practice in multinational law firms where he advised clients on a broad range of transactions, M&A, tax structuring, PE & VC fund formation and certain financial and insurance regulatory matters.Ìý

Benjamin Hippen is Senior Vice President and Head of Transplant Medicine and Emerging Capabilities, leading the companyÄ¢¹½´«Ã½™s worldwide efforts to expand access to transplantation. He received his bachelorÄ¢¹½´«Ã½™s degree in philosophy from Rice University and his medical degree from Baylor College of Medicine, and he completed his fellowship in nephrology and renal transplantation at the University of Alabama at Birmingham. ÌýHe is currently a Clinical Professor of Medicine at the University of North Carolina at Chapel Hill School of Medicine. Prior to joining Ä¢¹½´«Ã½, Dr. Hippen was a full-time general and transplant nephrologist and physician partner with Metrolina Nephrology Associates, a 38-nephrologist private practice in Charlotte, North Carolina, where he served as medical director of both a large in-center dialysis facility and home therapies unit. He is the author of more than 60 peer-reviewed manuscripts focused on ethics and public policy issues in nephrology and transplantation.